• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种氧敏感的可降解肽探针,用于肿瘤缺氧诱导因子-1 活性区域的成像。

Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors.

机构信息

Radioisotopes Research Laboratory, Kyoto University Hospital, Faculty of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

出版信息

Mol Imaging Biol. 2013 Dec;15(6):713-21. doi: 10.1007/s11307-013-0647-6.

DOI:10.1007/s11307-013-0647-6
PMID:23689986
Abstract

PURPOSE

We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors.

PROCEDURES

We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1α in proteasomes ((123/125)I-DKOP30 or (125)I-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed.

RESULTS

The (125)I-DKOP30 underwent degradation in a proteasome-dependent manner, while (125)I-mDKOP was not degraded. Biodistribution analysis showed (125)I-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of (125)I-DKOP30 coincided with the HIF-1α-positive hypoxic regions. Tumoral accumulation of (125)I-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of (125)I-mDKOP was not.

CONCLUSION

(123)I-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.

摘要

目的

我们旨在开发一种用于成像缺氧诱导因子-1(HIF-1)活性肿瘤的放射性标记肽探针。

过程

我们合成了含有或缺乏蛋白酶体中 HIF-1α 氧依赖性降解必需序列的肽探针((123/125)I-DKOP30 或(125)I-mDKOP,分别)。使用含有蛋白酶体的细胞裂解物评估探针的体外降解情况。还进行了体内生物分布研究、平面成像、放射自显影以及探针积累与 HIF-1 转录活性之间的比较。

结果

(125)I-DKOP30 以蛋白酶体依赖性方式降解,而(125)I-mDKOP 则未降解。生物分布分析显示(125)I-DKOP30 在肿瘤中的积累。通过体内成像可以清楚地观察到肿瘤,(125)I-DKOP30 的肿瘤内分布与 HIF-1α 阳性缺氧区域一致。(125)I-DKOP30 的肿瘤积累与 HIF-1 依赖性荧光素酶生物发光显著相关,而(125)I-mDKOP 则没有。

结论

(123)I-DKOP30 是一种用于成像 HIF-1 活性肿瘤的有用肽探针。

相似文献

1
Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors.开发一种氧敏感的可降解肽探针,用于肿瘤缺氧诱导因子-1 活性区域的成像。
Mol Imaging Biol. 2013 Dec;15(6):713-21. doi: 10.1007/s11307-013-0647-6.
2
Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells.使用一种能有效递送至HIF-1活性肿瘤细胞并在其中特异性稳定的蛋白质对HIF-1活性肿瘤缺氧进行成像。
J Nucl Med. 2009 Jun;50(6):942-9. doi: 10.2967/jnumed.108.061119. Epub 2009 May 14.
3
Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistry.评估 [125I]IPOS 作为肿瘤乏氧诱导因子-1 活性区域的分子成像探针:单光子发射计算机断层扫描/ X 射线计算机断层扫描成像、放射自显影和免疫组织化学的比较。
Cancer Sci. 2011 Nov;102(11):2090-6. doi: 10.1111/j.1349-7006.2011.02057.x. Epub 2011 Sep 15.
4
Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments.靶向缺氧诱导因子-1活性肿瘤微环境的放射性标记探针。
ScientificWorldJournal. 2014;2014:165461. doi: 10.1155/2014/165461. Epub 2014 Aug 18.
5
In vivo visualization of heterogeneous intratumoral distribution of hypoxia-inducible factor-1α activity by the fusion of high-resolution SPECT and morphological imaging tests.通过高分辨率单光子发射计算机断层扫描(SPECT)与形态学成像检查的融合实现肿瘤内缺氧诱导因子-1α活性异质性分布的体内可视化。
J Biomed Biotechnol. 2012;2012:262741. doi: 10.1155/2012/262741. Epub 2012 Jun 12.
6
PET imaging of hypoxia-inducible factor-1-active tumor cells with pretargeted oxygen-dependent degradable streptavidin and a novel 18F-labeled biotin derivative.采用靶向氧依赖型可降解链霉亲和素和新型 18F 标记生物素衍生物对缺氧诱导因子-1 活性肿瘤细胞进行 PET 成像。
Mol Imaging Biol. 2011 Oct;13(5):1003-10. doi: 10.1007/s11307-010-0418-6.
7
[Development of a method of high-contrasted nuclear medical imaging of hypoxia-inducible factor-1-active tumor by using a pretargeting approach].
Yakugaku Zasshi. 2012;132(5):595-600. doi: 10.1248/yakushi.132.595.
8
In vivo bioluminescence imaging monitoring of hypoxia-inducible factor 1alpha, a promoter that protects cells, in response to chemotherapy.体内生物发光成像监测缺氧诱导因子1α,一种保护细胞的启动子,对化疗的反应。
AJR Am J Roentgenol. 2008 Dec;191(6):1779-84. doi: 10.2214/AJR.07.4060.
9
Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha.缺氧诱导因子-1 活性肿瘤的快速检测:通过类似缺氧诱导因子-1α的机制进行蛋白降解的靶向前成像。
Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1566-74. doi: 10.1007/s00259-010-1467-4. Epub 2010 Apr 29.
10
Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.选择性杀伤缺氧诱导因子-1活性细胞可提高侵袭性和转移性胰腺癌小鼠模型的生存率。
Clin Cancer Res. 2009 May 15;15(10):3433-41. doi: 10.1158/1078-0432.CCR-08-2267. Epub 2009 May 5.

引用本文的文献

1
The molecular blueprint of targeted radionuclide therapy.靶向放射性核素治疗的分子蓝图。
Nat Rev Clin Oncol. 2025 Sep 9. doi: 10.1038/s41571-025-01069-z.
2
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.针对肿瘤微环境的放射性核素成像与治疗:一种用于个体化医疗的多癌种方法。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4616-4641. doi: 10.1007/s00259-022-05870-1. Epub 2022 Jul 5.
3
Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments.

本文引用的文献

1
Passing the baton: the HIF switch.接力棒传递:HIF 开关。
Trends Biochem Sci. 2012 Sep;37(9):364-72. doi: 10.1016/j.tibs.2012.06.004. Epub 2012 Jul 18.
2
In vivo visualization of heterogeneous intratumoral distribution of hypoxia-inducible factor-1α activity by the fusion of high-resolution SPECT and morphological imaging tests.通过高分辨率单光子发射计算机断层扫描(SPECT)与形态学成像检查的融合实现肿瘤内缺氧诱导因子-1α活性异质性分布的体内可视化。
J Biomed Biotechnol. 2012;2012:262741. doi: 10.1155/2012/262741. Epub 2012 Jun 12.
3
[Development of a method of high-contrasted nuclear medical imaging of hypoxia-inducible factor-1-active tumor by using a pretargeting approach].
靶向缺氧诱导因子-1活性肿瘤微环境的放射性标记探针。
ScientificWorldJournal. 2014;2014:165461. doi: 10.1155/2014/165461. Epub 2014 Aug 18.
4
Gallium-68-labeled anti-HER2 single-chain Fv fragment: development and in vivo monitoring of HER2 expression.镓-68标记的抗HER2单链Fv片段:HER2表达的研发与体内监测
Mol Imaging Biol. 2015 Feb;17(1):102-10. doi: 10.1007/s11307-014-0769-5.
Yakugaku Zasshi. 2012;132(5):595-600. doi: 10.1248/yakushi.132.595.
4
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.缺氧诱导因子:癌症进展的介质和癌症治疗的靶点。
Trends Pharmacol Sci. 2012 Apr;33(4):207-14. doi: 10.1016/j.tips.2012.01.005. Epub 2012 Mar 6.
5
Hypoxia-inducible factors in physiology and medicine.缺氧诱导因子在生理学和医学中的作用
Cell. 2012 Feb 3;148(3):399-408. doi: 10.1016/j.cell.2012.01.021.
6
Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo.精氨酸丰富的细胞穿透肽在肿瘤中的积累及其在体内抗癌药物递送的潜力。
J Control Release. 2012 Apr 30;159(2):181-8. doi: 10.1016/j.jconrel.2012.01.016. Epub 2012 Jan 21.
7
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression.缺氧诱导因子 1α(HIF1α)和缺氧诱导因子 2α(HIF2α):在缺氧肿瘤生长和进展中的兄弟之争。
Nat Rev Cancer. 2011 Dec 15;12(1):9-22. doi: 10.1038/nrc3183.
8
How can we overcome tumor hypoxia in radiation therapy?我们如何克服放射治疗中的肿瘤缺氧?
J Radiat Res. 2011;52(5):545-56. doi: 10.1269/jrr.11056.
9
Oxygen sensing, homeostasis, and disease.氧感知、内稳态与疾病。
N Engl J Med. 2011 Aug 11;365(6):537-47. doi: 10.1056/NEJMra1011165.
10
Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistry.评估 [125I]IPOS 作为肿瘤乏氧诱导因子-1 活性区域的分子成像探针:单光子发射计算机断层扫描/ X 射线计算机断层扫描成像、放射自显影和免疫组织化学的比较。
Cancer Sci. 2011 Nov;102(11):2090-6. doi: 10.1111/j.1349-7006.2011.02057.x. Epub 2011 Sep 15.